Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar.
Shwe Sin KyawGilles DelmasTom L DrakeOlivier CelhayWirichada Pan-NgumSasithon PukrittayakameeYoel LubellRicardo J AguasRichard James MaudeLisa J WhiteFrancois NostenPublished in: BMC public health (2021)
This cost analysis can assist policymakers in determining the resources required to clear malaria parasite reservoirs. The analysis demonstrated the value of using financial data from research activities to predict programmatic implementation costs of targeting MDA to different numbers of target villages.